InvestorsHub Logo

Cameo Brien

03/16/22 7:34 PM

#50 RE: Cameo Brien #49

"These assets form the foundation for our ability to strengthen our product pipeline, and enhance our position as a leader in the field of Gamma Delta-T based immuno-oncology.